European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Deferasirox Mylan, deferasirox, Date of authorisation: 26/09/2019, Revision: 13, Status: Authorised

Submitted by Anonymous (not verified) on 12 June 2026 - 11:40

Human medicines European public assessment report (EPAR): Deferasirox Mylan, deferasirox, Date of authorisation: 26/09/2019, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Azacitidine Mylan, azacitidine, Date of authorisation: 27/03/2020, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 12 June 2026 - 10:30

Human medicines European public assessment report (EPAR): Azacitidine Mylan, azacitidine, Date of authorisation: 27/03/2020, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Fubelv, etanercept, Date of authorisation: 23/04/2026, Revision: 1, Status: Authorised

Submitted by Anonymous (not verified) on 12 June 2026 - 10:22

Human medicines European public assessment report (EPAR): Fubelv, etanercept, Date of authorisation: 23/04/2026, Revision: 1, Status: Authorised

Clinical Trials Information System (CTIS) bitesize talk: Annual safety report (ASR) new safety module, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 23 July 2026, 13:00 (CEST) to 23 July 2026, 14:30 (CEST)

Submitted by Anonymous (not verified) on 12 June 2026 - 10:00

Clinical Trials Information System (CTIS) bitesize talk: Annual safety report (ASR) new safety module, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 23 July 2026, 13:00 (CEST) to 23 July 2026, 14:30 (CEST)

Human medicines European public assessment report (EPAR): Apremilast Accord, apremilast, Date of authorisation: 19/04/2024, Revision: 5, Status: Authorised

Submitted by Anonymous (not verified) on 12 June 2026 - 10:00

Human medicines European public assessment report (EPAR): Apremilast Accord, apremilast, Date of authorisation: 19/04/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Posaconazole Accord, posaconazole, Date of authorisation: 25/07/2019, Revision: 13, Status: Authorised

Submitted by Anonymous (not verified) on 12 June 2026 - 9:08

Human medicines European public assessment report (EPAR): Posaconazole Accord, posaconazole, Date of authorisation: 25/07/2019, Revision: 13, Status: Authorised

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – June 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 June 2026, 16:30 (CEST) to 12 June 2026, 17:30 (CEST)

Submitted by Anonymous (not verified) on 12 June 2026 - 9:00

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – June 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 June 2026, 16:30 (CEST) to 12 June 2026, 17:30 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More